Patent 10251911 was granted and assigned to Entegrion, Inc. on April, 2019 by the United States Patent and Trademark Office.
The technology relates to spray dried plasma and methods of making the same. The method includes providing plasma to a spray drying apparatus, spray drying the plasma, at the spray drying apparatus, to form physiologically active plasma powder, the spray drying apparatus configured utilizing one or more parameters, and storing the physiologically active plasma powder.